Cargando…
Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
Kawasaki disease (KD) is a systemic vasculitis mainly affecting young children and the leading cause of acquired heart disease in developed countries. We performed a self-controlled case series analysis to investigate the association between PCV13 and KD. All hospitalized KD cases <2 y old from o...
Autores principales: | Yung, Chee Fu, Ma, Xiangmei, Cheung, Yin Bun, Oh, Bee Khiam, Soh, Sally, Thoon, Koh Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788987/ https://www.ncbi.nlm.nih.gov/pubmed/31604998 http://dx.doi.org/10.1038/s41598-019-51137-5 |
Ejemplares similares
-
Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
por: Yung, Chee Fu, et al.
Publicado: (2021) -
Epidemiologic trends in Kawasaki disease during coronavirus disease-19 in Singapore
por: Yung, Chee Fu, et al.
Publicado: (2020) -
Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Esposito, Susanna, et al.
Publicado: (2015) -
Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly
por: Kislaya, Irina, et al.
Publicado: (2019) -
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019)